Actinium Pharmaceuticals, Inc. - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-08-30

Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-30	Common Stock	S	23500	$1.8	Disposed	4878988	Direct
2016-08-30	Common Stock	S	1500	$1.805	Disposed	4877488	Direct
2016-08-30	Common Stock	S	30474	$1.81	Disposed	4847014	Direct
2016-08-30	Common Stock	S	200	$1.8125	Disposed	4846814	Direct
2016-08-30	Common Stock	S	300	$1.815	Disposed	4846514	Direct
2016-08-30	Common Stock	S	100	$1.82	Disposed	4846414	Direct
2016-08-31	Common Stock	S	25188	$1.8	Disposed	4821226	Direct
2016-08-31	Common Stock	S	6400	$1.81	Disposed	4814826	Direct
2016-08-31	Common Stock	S	200	$1.815	Disposed	4814626	Direct
2016-08-31	Common Stock	S	25100	$1.82	Disposed	4789526	Direct
2016-08-31	Common Stock	S	800	$1.83	Disposed	4788726	Direct
2016-08-31	Common Stock	S	15000	$1.84	Disposed	4773726	Direct
2016-08-31	Common Stock	S	40200	$1.85	Disposed	4733526	Direct
2016-08-31	Common Stock	S	9800	$1.86	Disposed	4723726	Direct
2016-08-31	Common Stock	S	14165	$1.87	Disposed	4709561	Direct